EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review

Angela Lee iD, Renatta Knox, Margaret Reynolds, Erin McRoy, Hoanh Nguyen iD

JIMD Reports · 2023-11 · 64 (6) · 417-423

DOI: 10.1002/jmd2.12395 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JIMD Reports, 2023-09. Verfasst von Angela Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Genetics and Genomic Medicine Washington University Saint Louis Missouri USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phospho‐ribosyl‐pyrophosphate synthetase 1 (PRPS1) deficiency is secondary to loss of function variants in PRPS1 . This enzyme generates phospho‐ribosyl‐pyrophosphate (PRPP), which is utilized in the synthesis of purines, nicotinamide adenine dinucleotide (NAD), and NAD phosphate (NADP), among other metabolic pathways. Arts syndrome, or severe PRPS1 deficiency, is an X‐linked condition characterized by congenital sensorineural hearing loss, optic atrophy, developmental delays, ataxia, hypotonia, and recurrent infections that can cause progressive clinical decline, often resulting in death before 5 years of age. Supplementation of the purine and NAD pathways outside of PRPP‐dependent reactions is a logical approach and has been reported in a handful of patients, two with S‐adenosylmethionine (SAMe) and one with SAMe and nicotinamide riboside (NR). We present the clinical course of a fourth Arts syndrome patient who was started on therapy and review previously reported patients. All patients had stability or improvement of symptoms, suggesting that SAMe and NR can be a treatment option in Arts syndrome, though further studies are warranted.

Schlagwörter

Stichwörter der Autor:innen

Arts syndromePRPPPRPS1S‐adenosylmethioninenicotinamide ribosidephosphoribosylpyrophosphate

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Genetics and Genomic Medicine Washington University Saint Louis Missouri USA.
  • Department of Pediatrics and Neurology Washington University Saint Louis Missouri USA.
  • Departments of Pediatrics, Division of Ophthalmology Washington University Saint Louis Missouri USA.

ORCID-Profile: Angela Lee, Hoanh Nguyen

Zitieren

APA

Lee, A., Knox, R., Reynolds, M., McRoy, E., & Nguyen, H. (2023). S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review. JIMD Reports, 64(6), 417-423. https://doi.org/10.1002/jmd2.12395

Vancouver

Lee A, Knox R, Reynolds M, McRoy E, Nguyen H. S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review. JIMD Reports. 2023;64(6):417-423. doi:10.1002/jmd2.12395

BibTeX
@article{Lee2023,
  author = {Lee, Angela and Knox, Renatta and Reynolds, Margaret and McRoy, Erin and Nguyen, Hoanh},
  title = {S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review},
  journal = {JIMD Reports},
  year = {2023},
  volume = {64},
  number = {6},
  pages = {417--423},
  doi = {10.1002/jmd2.12395}
}
Kostenlos starten →